5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.67▼ | 1.68▼ | 1.68▼ | 1.71▼ | 1.82▼ |
MA10 | 1.68▼ | 1.67▼ | 1.68▼ | 1.79▼ | 1.70▼ |
MA20 | 1.68▼ | 1.69▼ | 1.70▼ | 1.80▼ | 1.78▼ |
MA50 | 1.68▼ | 1.71▼ | 1.74▼ | 1.69▼ | 1.96▼ |
MA100 | 1.70▼ | 1.76▼ | 1.82▼ | 1.78▼ | 2.30▼ |
MA200 | 1.73▼ | 1.82▼ | 1.70▼ | 1.90▼ | 3.19▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.000▲ | 0.000▼ | -0.026▼ | 0.015▲ |
RSI | 43.283▼ | 42.602▼ | 40.736▼ | 44.466▼ | 46.181▼ |
STOCH | 20.833 | 45.508 | 26.953 | 34.070 | 50.197 |
WILL %R | -100.000▼ | -84.615▼ | -90.476▼ | -78.846▼ | -64.789 |
CCI | -100.404▼ | -69.265 | -88.870 | -99.709 | -28.916 |
MA | $GANX Price Crossed Below MA(50) | Set Alert |
Thursday, September 04, 2025 05:15 AM
Ongoing Phase 1b trial of GT-02287 to be extended by an additional nine months for participants who enrolled in the original three-month study design The independent data monitoring committee (DMC) ...
|
Friday, August 22, 2025 12:25 AM
Gain Therapeutics, Inc. ( (GANX)) has released its Q2 earnings. Here is a breakdown of the information Gain Therapeutics, Inc. presented to its investors. Take advantage of TipRanks Premium at 50% off ...
|
Tuesday, August 12, 2025 08:24 PM
Roth Capital lowered the firm’s price target on Gain Therapeutics (GANX) to $6 from $7 and keeps a Buy rating on the shares after meeting with its CEO to discuss the company’s Phase 1b study ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
12/09/25 | 1.73 | 1.7488 | 1.65 | 1.66 | 508,818 |
11/09/25 | 1.75 | 1.78 | 1.67 | 1.72 | 646,338 |
10/09/25 | 1.72 | 1.7357 | 1.69 | 1.73 | 299,290 |
09/09/25 | 1.76 | 1.77 | 1.69 | 1.71 | 483,119 |
08/09/25 | 1.77 | 1.805 | 1.72 | 1.75 | 769,525 |
05/09/25 | 1.77 | 1.82 | 1.72 | 1.76 | 502,534 |
04/09/25 | 1.95 | 1.95 | 1.55 | 1.74 | 2,184,699 |
03/09/25 | 2.03 | 2.0499 | 1.84 | 1.92 | 483,951 |
02/09/25 | 1.95 | 2.0474 | 1.86 | 1.91 | 667,361 |
29/08/25 | 1.91 | 2.02 | 1.89 | 1.99 | 599,869 |
|
|
||||
|
|
||||
|
|